Harvard Biotechnology Club Awards NeuroHealing Pharmaceuticals First Prize in Business Plan Competition
At the awards ceremony hosted by Brown Rudnick Berlack Israels LLP, the judges described NeuroHealing's concept to be solid, novel and addressing an attractive, unserved market. Discussing the review of many outstanding companies, Patrick Loerch, the director of the competition, said
"NeuroHealing's excellent management team, experienced in the target market and development process, resulted in a clear winner this year." Judges included representatives from the following venture firms: BioVentures Investors, Boston Millennia Partners, CDP Capital, Flagship Ventures, MPM Capital, Oxford Bioscience Partners, Polaris Ventures and Versant Ventures.
"This award recognizes the founders, Daniel Katzman and Esteban Fridman's, innovative concept of the need for a drug therapy approach to the neuro- rehabilitation market, and the work of Elkan Gamzu, Chairman, Irit Aish and the entire team in establishing our clinical programs," said Neal Farber, CEO of NeuroHealing. "In addition, we thank the Harvard Biotechnology Club and the judges for this honor and exposure, as we progress in our fundraising efforts."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.